Cetera Investment Advisers’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.33M Sell
25,787
-302
-1% -$27.7K ﹤0.01% 2153
2025
Q4
$2.35M Buy
26,089
+260
+1% +$24.7K ﹤0.01% 2071
2025
Q3
$2.54M Buy
25,829
+3,298
+15% +$327K ﹤0.01% 1968
2025
Q2
$2.06M Sell
22,531
-1,338
-6% -$129K ﹤0.01% 1826
2025
Q1
$2.7M Sell
23,869
-1,745
-7% -$187K 0.01% 1533
2024
Q4
$2.71M Sell
25,614
-33,014
-56% -$3.54M 0.01% 1427
2024
Q3
$6.33M Sell
58,628
-2,633
-4% -$287K 0.01% 893
2024
Q2
$6.65M Sell
61,261
-3,230
-5% -$381K 0.02% 853
2024
Q1
$8.51M Buy
64,491
+5,454
+9% +$681K 0.02% 728
2023
Q4
$7.18M Sell
59,037
-4,558
-7% -$509K 0.06% 320
2023
Q3
$7.14M Sell
63,595
-1,469
-2% -$187K 0.06% 303
2023
Q2
$9.47M Sell
65,064
-518
-0.8% -$70.4K 0.08% 233
2023
Q1
$8.47M Sell
65,582
-5,162
-7% -$648K 0.07% 249
2022
Q4
$9.02M Buy
70,744
+4,615
+7% +$536K 0.08% 231
2022
Q3
$6.91M Sell
66,129
-2,662
-4% -$292K 0.14% 156
2022
Q2
$7.23M Sell
68,791
-532
-0.8% -$63.1K 0.12% 185
2022
Q1
$8.87M Sell
69,323
-615
-0.9% -$74.1K 0.13% 165
2021
Q4
$8.63M Buy
69,938
+64,329
+1,147% +$8.42M 0.12% 176
2021
Q3
$797K Buy
5,609
+126
+2% +$18.5K 0.01% 872
2021
Q2
$856K Buy
5,483
+1,738
+46% +$282K 0.01% 837
2021
Q1
$582K Sell
3,745
-1,941
-34% -$301K 0.01% 893
2020
Q4
$851K Buy
+5,686
New +$803K 0.02% 730

Other funds holding ZBH

Cetera Investment Advisers's ZBH Position: Q1 2026 in Review

Cetera Investment Advisers reduced its Zimmer Biomet (ZBH) stake by 1.2% in Q1 2026, selling an estimated $27.7K and leaving 25,787 shares worth $2.33M. The position accounts for ﹤0.01% of the portfolio, ranked #2153.

Cetera Investment Advisers first reported a position in ZBH in Q4 2020 and has held it in 22 quarters since. The position peaked at $9.47M in Q2 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Cetera Investment Advisers held 25,787 shares of Zimmer Biomet worth $2.33M as of Q1 2026.
  • Cetera Investment Advisers sold 302 Zimmer Biomet shares in Q1 2026, an estimated $27.7K.
  • Zimmer Biomet made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #2153 holding.
  • Cetera Investment Advisers first reported a position in Zimmer Biomet in Q4 2020 and has held it in 22 quarters since.
  • Cetera Investment Advisers's Zimmer Biomet position peaked at $9.47M in Q2 2023.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.